在综合性瘤学中的真菌衍生补充剂
Caroline Mohammed1, Ashley E Aaroe2, Greg Buchold2
1Department of Neurology, University of North Carolina at Chapel Hill, NC.
The American journal of medicine
|January 14, 2026
概括
补充剂对癌症患者来说是有前途的,提供免疫调节,神经保护和抗氧化剂的好处. 需要进一步的研究来将这些自然疗法整合到传统的癌症护理中,以改善患者的福祉.
科学领域:
- 综合性瘤学 综合性瘤学
- 药理学 药理学是指药理学的学科.
- 菌类学 菌类学是指菌类学.
背景情况:
- 对用于支持癌症患者的真菌衍生补充剂的兴趣日益增长.
- 临床前和临床研究表明,真菌具有免疫调节,神经保护和抗氧化作用.
- 在当前的癌症护理实践中,这些自然方法的整合有限.
研究的目的:
- 突出菌补充剂在癌症患者护理中的潜在好处.
- 鼓励对使用真菌作为补充疗法进行更广泛的研究.
- 促进将真菌衍生补充剂纳入综合医学框架.
主要方法:
- 关于真菌活动的临床前动物研究的审查.
- 对支持真菌益处的人类临床研究的分析.
- 汇编了示例,证明了对患者福祉的积极影响.
主要成果:
- 补充剂具有显著的免疫调节,神经保护和抗氧化特性.
- 来自动物和人类研究的证据支持这些治疗潜力.
- 有记录的病例显示,对患者的整体幸福感有积极的贡献.
结论:
- 来自真菌的补充剂为改善癌症患者护理提供了一个有希望的途径.
- 需要增加医疗保健专业人员对这些天然产品的使用和研究.
- 将真菌补充剂纳入癌症治疗计划可以支持患者的福祉.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Fungal Phylum Microsporidia
425
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
425


